ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Prothena and Novo Nordisk Agreement for ATTR Amyloidosis Program
July 13, 2021Novo Nordisk A/S has acquired Prothena Corporation’s clinical-stage antibody PRX004 and broader ATTR amyloidosis program. -
Prothena announces new COO
June 27, 2018Nguyen currently serves on the board of directors of Sierra Oncology, Inc., a public clinical-stage oncology company and Rain Therapeutics Inc., a private clinical-stage oncology company. -
After AL amyloidosis flop, Prothena slashes workforce by 57%
May 29, 2018To say that Prothena had a turbulent year would be an understatement. In the span of a month, the biotech went from inking an R&D deal with Celgene worth up to $2 billion to dumping its lead asset -
Prothena scratches MCAM psoriasis antibody after negative trial
September 30, 2017Prothena had previously suggested that the drug could have potential in progressive MS, which is particularly resistant to current therapies.
Pharma Sources Insight January 2025
